Blood components for topical use in tissue regeneration: evaluation of corneal lesions treated with platelet lysate and considerations on repair mechanisms.

BACKGROUND The fields of application of topically administered platelet derivatives are numerous and increasing. The use of this blood component is based on the fact that it contains growth factors and proteins of the clotting system. Studies carried out so far have been aimed at identifying these substances, assaying their content in the various types of platelet concentrate used, determining the in vivo and in vitro mechanisms of action, and trying to standardise the production methods. However, much still remains to be discovered, not only about the growth factors, but also about all those cytokines and biochemical mediators that are involved in the processes of tissue regeneration. METHODS We studied the use of platelet lysate, obtained from platelet-rich plasma which had been frozen, for the treatment of corneal ulcers caused by neurotrophic keratitis and of epithelial and stromal loss following physical or chemical trauma. The platelet lysate was administered in the form of eye drops to patients who had not responded to conventional therapy and who were at risk of corneal scarring. RESULTS The results were satisfactory in terms of both tissue regeneration and healing time. The clinical follow-up showed a clear reduction in the time of regeneration of the damaged epithelium and stabilisation of the repair process. The epithelial defects disappeared completely in all the treated eyes within 6 to 32 days, with the time depending on the type of lesion and the severity of the damage. CONCLUSIONS The cornea reacts to damage by releasing numerous substances, including cytokines, growth factors, proteases and neuropeptides in order to restore its anatomical integrity. A change in the balance between inhibitory and stimulating substances can lead to the development of complications. Fast, correct re-epithelialisation is fundamental for the formation of new, transparent tissue. The use of non-gelified platelet-rich plasma was found to be effective in all cases with loss of epithelium, such as post-herpetic corneal ulcers or ulcers occurring following trauma or exposure to caustic substances.

[1]  Brendan Kilpatrick,et al.  Regeneration , 1908, The American Naturalist.

[2]  D. Greenhalgh,et al.  Cutaneous Wound Healing , 2007, Journal of burn care & research : official publication of the American Burn Association.

[3]  L. Mazzucco,et al.  Tissue regeneration and in loco administration of platelet derivatives: clinical outcome, heterogeneous products, and heterogeneity of the effector mechanisms , 2005, Transfusion.

[4]  P. McMillan,et al.  Bone formation in the maxillary sinus by using platelet-rich plasma: an experimental study in sheep. , 2005, The Journal of oral implantology.

[5]  T. Wedel,et al.  Epitheliotrophic capacity of a growth factor preparation produced from platelet concentrates on corneal epithelial cells: a potential agent for the treatment of ocular surface defects? , 2004, Transfusion.

[6]  B. Vote,et al.  Autologous platelets for macular hole surgery: the Sussex Eye Hospital experience , 2004, Clinical & experimental ophthalmology.

[7]  A. Borean,et al.  Chronic Skin Ulcers: A Regenerative Simulation by Topical Hemotherapy , 2004, The International journal of artificial organs.

[8]  E. Lacoste,et al.  Effects of calcium and thrombin on growth factor release from platelet concentrates: kinetics and regulation of endothelial cell proliferation. , 2004, Biomaterials.

[9]  A. Levis,et al.  The use of autologous platelet gel to treat difficult‐to‐heal wounds: a pilot study , 2004, Transfusion.

[10]  L. Mazzucco,et al.  Regarding "Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers". , 2004, Journal of vascular surgery.

[11]  T. Hansen,et al.  Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. , 2004, Bone.

[12]  G. Crovetti,et al.  Platelet gel for healing cutaneous chronic wounds. , 2004, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[13]  M. Guglielmotti,et al.  Effect of Platelet-Rich Plasma on the Peri-implant Bone Response:: An Experimental Study , 2004, Implant dentistry.

[14]  G. Watzek,et al.  Proliferation of dental pulp fibroblasts in response to thrombin involves mitogen-activated protein kinase signalling. , 2004, International endodontic journal.

[15]  L. Dubertret,et al.  Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers. , 2003, Journal of vascular surgery.

[16]  M. Somerman,et al.  Growth and amelogenin-like factors in periodontal wound healing. A systematic review. , 2003, Annals of periodontology.

[17]  J. Wiltfang,et al.  Sample preparation technique and white cell content influence the detectable levels of growth factors in platelet concentrates , 2003, Vox sanguinis.

[18]  U. Kellner,et al.  Long-term results following pars plana vitrectomy with platelet concentrate in pediatric patients with traumatic macular hole. , 2003, American journal of ophthalmology.

[19]  T. Nakajima,et al.  Basic Studies on the Clinical Applications of Platelet-Rich Plasma , 2003, Cell transplantation.

[20]  L Sedel,et al.  A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. , 2003, Biomaterials.

[21]  G. Hafner,et al.  Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. , 2002, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[22]  S. Bhanot,et al.  Current Applications of Platelet Gels in Facial Plastic Surgery , 2002, Facial plastic surgery : FPS.

[23]  S. Froum,et al.  Effect of platelet-rich plasma on bone growth and osseointegration in human maxillary sinus grafts: three bilateral case reports. , 2002, The International journal of periodontics & restorative dentistry.

[24]  E. Snyder,et al.  Topical platelet growth factor therapy: of lotions and potions , 2001, Transfusion.

[25]  L. Pivacek,et al.  Autologous platelet‐rich plasma isolated using the Haemonetics Cell Saver 5 and Haemonetics MCS+ for the preparation of platelet gel , 2001, Vox sanguinis.

[26]  M. R. Jackson,et al.  Fibrin sealants in surgical practice: An overview. , 2001, American journal of surgery.

[27]  Pankaj S Mankad M.B.B.S,et al.  The role of fibrin sealants in hemostasis. , 2001 .

[28]  K. Tabuchi,et al.  Relief of Post‐Tonsillectomy Pain by Release of Lidocaine From Fibrin Glue , 2001, The Laryngoscope.

[29]  M. Nasu,et al.  Bioactivity of the Vascular Endothelial Growth Factor Trapped in Fibrin Clots: Production of IL-6 and IL-8 in Monocytes by Fibrin Clots , 2001, Pathophysiology of Haemostasis and Thrombosis.

[30]  D. Albala,et al.  Fibrin glue applications in urology , 2001, Current urology reports.

[31]  M. Bostrom,et al.  Bone growth factors. , 2000, The Orthopedic clinics of North America.

[32]  B. Brkljačić,et al.  Fibrin Glue-Antibiotic Mixture in the Treatment of Anal Fistulae: Experience with 69 Cases , 2000, Digestive Surgery.

[33]  H. Klüter,et al.  Preparation of autologous platelets for the ophthalmologic treatment of macular holes , 1999, Transfusion.

[34]  R. Marx,et al.  Platelet-rich plasma: Growth factor enhancement for bone grafts. , 1998, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[35]  D. M. Green,et al.  Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. , 1997, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[36]  W. Spotnitz,et al.  Fibrin Tissue Adhesives , 1997, Thrombosis and Haemostasis.

[37]  C. Featherstone.  Fibrin sealants for haemostasis and drug delivery , 1997, The Lancet.

[38]  J. Korobelnik,et al.  Autologous platelet concentrate as an adjunct in macular hole healing: a pilot study. , 1996, Ophthalmology.

[39]  M. Slater,et al.  Involvement of platelets in stimulating osteogenic activity , 1995, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[40]  E. Canalis,et al.  Clinical review 35: Growth factors and their potential clinical value. , 1992, The Journal of clinical endocrinology and metabolism.

[41]  L. Phillips,et al.  Platelet-derived growth factor BB for the treatment of chronic pressure ulcers , 1992, The Lancet.

[42]  K. Miyazono,et al.  Platelet-derived growth factors. , 1989, Blood reviews.

[43]  Antoniades Hn,et al.  Human platelet-derived growth factor: structure and function. , 1983, Federation proceedings.

[44]  C. Stiles,et al.  Platelet alpha granules contain a growth factor for fibroblasts. , 1979, Blood.

[45]  S. Flamini,et al.  Closed surgery: autologous platelet gel for the treatment of pseudoarthrosis , 2004 .

[46]  B. Woda,et al.  Expression of Translation Initiation Factors eIF-4E and eIF-2α and a Potential Physiologic Role of Continuous Protein Synthesis in Human Platelets , 2001, Thrombosis and Haemostasis.

[47]  M. Codispoti,et al.  The role of fibrin sealants in hemostasis. , 2001, American journal of surgery.

[48]  Ochsner Mg.  Fibrin solutions to control hemorrhage in the trauma patient. , 1998 .

[49]  M. Ochsner.  Fibrin solutions to control hemorrhage in the trauma patient. , 1998, Journal of long-term effects of medical implants.

[50]  The potential role of growth and differentiation factors in periodontal regeneration. , 1996, Journal of periodontology.